Accelrys Inc. (ACCL)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: SERVICES-PREPACKAGED SOFTWARE
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

10188 TELESIS COURT, SUITE 100 SAN DIEGO, CA 92121-3752

Accelrys Inc. develops and commercializes molecular modeling, simulation, informatics, and decision support software for the life sciences and materials research markets. The company has a product suite consisting of over 100 application modules based on proprietary technologies.

View SEC Filings from ACCL instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ACCL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ACCL BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HAHN MATHEW A CHIEF TECHNOLOGY OFFICER

  • Officer
No longer subject to file 2014-04-29 0

OHRN-HICKS JUDITH M. SVP, HUMAN RESOURCES

  • Officer
No longer subject to file 2014-04-29 0

RODEK JEFFREY R

  • Director
No longer subject to file 2014-04-29 0

FERGUSON LARRY RICHARD

  • Director
No longer subject to file 2014-04-29 0

SCIPIO MAXIMUS CARNECCHIA CHIEF EXECUTIVE OFFICER

  • Officer
No longer subject to file 2014-04-29 0

PIRAINO MICHAEL EVP AND CFO

  • Officer
No longer subject to file 2014-04-29 0

HARKNESS TIMOTHY

  • Director
No longer subject to file 2014-04-29 0

VAN INGEN CHRIS

  • Director
No longer subject to file 2014-04-29 0

MOLLIE HUNTER SVP GLOBAL SALES & SERVICES

  • Officer
No longer subject to file 2014-04-29 0

PEDERSEN LEIF E SEE REMARKS

  • Officer
No longer subject to file 2014-04-29 0

GRAY JASON SVP, GENERAL COUNSEL

  • Officer
No longer subject to file 2014-04-29 0

HIRAOKA SCOTT SVP, R&D

  • Officer
No longer subject to file 2014-04-29 0

MELIN HEIDI M

  • Director
No longer subject to file 2014-04-29 0

RGM CAPITAL, LLC

MOSES ROBERT G

  • 10% Owner
7,144,932 2014-01-06 0

THAKUR ANIL SR. VP, SW DEVELOPMENT

  • Officer
0 2013-03-14 0

LEVY RICARDO B

  • Director
0 2013-03-06 0

COLEMAN KENNETH L

  • Director
9,727 2012-08-24 0

MERSTEN DAVID R SVP AND GENERAL COUNSEL

  • Officer
25,000 2012-07-26 0

JOHNSON TODD EVP, CORP DEV & STRATEGY

  • Officer
12,664 2012-04-09 0

STEFFEN CHRISTOPHER J

  • Director
9,000 2011-12-30 0

PASTERNACK BRUCE A

  • Director
9,000 2011-12-30 0

BROWN FRANK K CHIEF SCIENCE OFFICER

  • Officer
5,087 2011-08-08 0

GOLDBY STEVEN D

  • Director
6,000 2011-08-03 0

HERITAGE TREVOR EVP PRODUCT STRATEGY

  • Officer
17,000 2011-08-03 0

BURRIN PAUL SVP & CHIEF MARKETING OFFICER

  • Officer
50,000 2009-12-14 0

RUSSO RICK CFO

  • Officer
5,353 2009-10-02 0

VOGT ILENE M SVP WW SALES AND SERVICES

  • Officer
6,425 2009-08-05 0

MAK CAPITAL ONE LLC

MAK CAPITAL FUND LP

KAUFMAN MICHAEL A

SUSSMAN S DONALD

  • 10% Owner
No longer subject to file 2009-04-14 0

SHYAM ROHIT VP CORP DEVELOPMENT & STRATEGY

  • Officer
5,354 2008-09-24 0

EMKJER MARK J PRESIDENT AND CEO

  • Officer
50,000 2008-08-07 0

AUSTIN NICK

  • FORMER VP, R&D
No longer subject to file 2007-08-26 0

MURPHY RICHARD C SVP, WORLDWIDE SALES AND SVCS

  • Officer
13,091 2007-06-20 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments